1. Home
  2. CELU vs SPRU Comparison

CELU vs SPRU Comparison

Compare CELU & SPRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • SPRU
  • Stock Information
  • Founded
  • CELU 2016
  • SPRU 2008
  • Country
  • CELU United States
  • SPRU United States
  • Employees
  • CELU N/A
  • SPRU N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • SPRU Auto Parts:O.E.M.
  • Sector
  • CELU Health Care
  • SPRU Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • SPRU Nasdaq
  • Market Cap
  • CELU 42.2M
  • SPRU 34.9M
  • IPO Year
  • CELU N/A
  • SPRU N/A
  • Fundamental
  • Price
  • CELU $2.00
  • SPRU $1.80
  • Analyst Decision
  • CELU
  • SPRU
  • Analyst Count
  • CELU 0
  • SPRU 0
  • Target Price
  • CELU N/A
  • SPRU N/A
  • AVG Volume (30 Days)
  • CELU 75.7K
  • SPRU 83.3K
  • Earning Date
  • CELU 05-08-2025
  • SPRU 08-13-2025
  • Dividend Yield
  • CELU N/A
  • SPRU N/A
  • EPS Growth
  • CELU N/A
  • SPRU N/A
  • EPS
  • CELU N/A
  • SPRU N/A
  • Revenue
  • CELU $54,220,000.00
  • SPRU $87,638,000.00
  • Revenue This Year
  • CELU $23.29
  • SPRU $2.12
  • Revenue Next Year
  • CELU N/A
  • SPRU N/A
  • P/E Ratio
  • CELU N/A
  • SPRU N/A
  • Revenue Growth
  • CELU 138.11
  • SPRU 9.48
  • 52 Week Low
  • CELU $1.00
  • SPRU $1.42
  • 52 Week High
  • CELU $5.22
  • SPRU $3.60
  • Technical
  • Relative Strength Index (RSI)
  • CELU 51.94
  • SPRU 39.48
  • Support Level
  • CELU $1.80
  • SPRU $1.92
  • Resistance Level
  • CELU $2.26
  • SPRU $2.23
  • Average True Range (ATR)
  • CELU 0.18
  • SPRU 0.16
  • MACD
  • CELU 0.02
  • SPRU -0.02
  • Stochastic Oscillator
  • CELU 48.25
  • SPRU 6.52

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

Share on Social Networks: